Genetic alterations and personalized medicine in melanoma: progress and future prospects.
about
Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic TargetsImmune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With ImmunotherapyEpigenetic regulation in human melanoma: past and futureOvercoming resistance to BRAF inhibition in BRAF-mutated metastatic melanomaTargeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas.Competitive allele-specific TaqMan PCR (Cast-PCR) is a sensitive, specific and fast method for BRAF V600 mutation detection in Melanoma patients.SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.mRNA-based dendritic cell immunization improves survival in ret transgenic mouse melanoma model.Identification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exerciseCell Cycle Regulation and Melanoma.Epigenetic Regulation of KPC1 Ubiquitin Ligase Affects the NF-κB Pathway in Melanoma.Development of a curriculum in molecular diagnostics, genomics and personalized medicine for dermatology trainees.Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein information.Neoadjuvant Model in Cancer Treatment: From Clinical Opportunity to Health-Care Utility.A comparison of immunohistochemical and molecular methods used for analyzing the BRAF V600E gene mutation in malignant melanoma in Taiwan.Immunohistochemical analysis of T-type calcium channels in acquired melanocytic naevi and melanoma.NF1 mutations in conjunctival melanoma.CDK4 inhibitors an emerging strategy for the treatment of melanomaPredominance of triple wild-type and IGF2R mutations in mucosal melanomas
P2860
Q26795735-A1A15F72-4C9E-4872-8823-B90CF71E13C3Q26796309-DFAEFEBB-6EFF-4DED-9BD6-314A86586A5FQ28085681-E7F646B1-FFE3-4013-998C-D8DAC91C863CQ34786402-88BA3F56-737E-415A-848A-CCDB25F883A9Q35896475-CAAA0B1B-D103-40AD-BC2B-00558CA89952Q36392912-6472FBC3-3153-42BD-BAA1-CC6C887860F8Q36962895-B39CDFB5-AE94-4F34-BB43-49F34380D222Q37079145-C111DE58-4DF2-4794-89B0-F889DDC6CA19Q37289465-EB8F201C-B20E-4A28-87AC-5C4C8AB17340Q38815527-28266A96-FB9C-4E45-AFA4-9216E50E8516Q38847201-A4A6892B-698B-413E-92E4-DD33B49BBBF9Q38872266-20082390-BA58-4DB0-BF29-9AD7B8FDE301Q43147493-DAA69312-FF7E-4A33-A0D9-EA9BC784D2E8Q44133547-407A9E10-1F53-4721-BCDA-4718EE4ABFD7Q50905729-9B1D984A-2F4A-4C8B-88C7-1A7601A0C79AQ51595959-7684671D-FDBB-4D75-A2D4-9012834DDCF7Q51777015-086E44AD-913C-4006-B7FC-89B43B31DFFCQ52646053-C5BA118E-B532-41B1-BD46-D2F4DC1FA13FQ57571832-7DDA26D2-39DE-4A02-AADA-0D6BB3EA773BQ58093307-B59DC9CE-7EE6-4B9E-98F1-237CF747F049
P2860
Genetic alterations and personalized medicine in melanoma: progress and future prospects.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Genetic alterations and personalized medicine in melanoma: progress and future prospects.
@en
type
label
Genetic alterations and personalized medicine in melanoma: progress and future prospects.
@en
prefLabel
Genetic alterations and personalized medicine in melanoma: progress and future prospects.
@en
P2860
P50
P356
P1476
Genetic alterations and personalized medicine in melanoma: progress and future prospects.
@en
P2093
John F Thompson
Klaus G Griewank
P2860
P304
P356
10.1093/JNCI/DJT435
P407
P577
2014-02-01T00:00:00Z